In vivo study of flow-rate accuracy of the MedStream programmable infusion system

Neuromodulation

Volumn 14, Issue 3, 2011, Pages 235-241

  Venugopalan, Ramakrishna ^a   Ginggen, Alec ^a   Bork, Toralf ^a   Anderson, William ^b   Buffen, Elaine ^a  

^a Research and Development Department of Codman and Shurtleff Inc   (United States)

^b Biostatistical Consultant   (United States)

Author keywords

Chronic pain; infusion pumps; programmable pump; sheep; spasticity

Indexed keywords

BUPRENORPHINE; CEFTIOFUR;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE SAFETY; ELECTROCARDIOGRAPHY; FLOW RATE; FLOW RATE ACCURACY; IMPLANTATION; IN VIVO STUDY; INFUSION PUMP; INFUSION RATE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL; RECTUM TEMPERATURE; RESERVOIR; SHEEP; WOUND INFECTION;

EID: 79958106963     PISSN: 10947159     EISSN: 15251403     Source Type: Journal    
DOI: 10.1111/j.1525-1403.2011.00353.x     Document Type: Article

References (31)

1. Haisma JA, van der Woude LH, Stam HJ, et al,. Complications following spinal cord injury: occurrence and risk factors in a longitudinal study during and after inpatient rehabilitation. J Rehabil Med 2007; 39: 393-398.
2. Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL,. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 2004; 10: 589-595. (Pubitemid 39207235)
3. Krigger KW,. Cerebral palsy: an overview. Am Fam Physician 2006; 73: 91-100. (Pubitemid 43161248)
4. Elovic EP, Zafonte R,. Spasticity management in traumatic brain injury. Phys Med Rehabil State Art Rev 2001; 15: 348.
5. Sommerfeld DK, Eek EU, Svensson AK, Holmqvist LW, von Arbin MH,. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke 2004; 35: 134-139. (Pubitemid 38057606)
6. Pfister AA, Roberts AG, Taylor HM, Noel-Spaudling S, Damian MM, Charles PD,. Spasticity in adults living in a developmental center. Arch Phys Med Rehabil 2003; 84: 1808-1812. (Pubitemid 37521233)
7. Smith TJ, Swainey C, Coyne PJ,. Pain management, including intrathecal pumps. Curr Oncol Rep 2004; 6: 291-296. (Pubitemid 39359499)
8. Koulousakis A, Kuchta J, Bayarassou A, Sturm V,. Intrathecal opioids for intractable pain syndromes. Acta Neurochir Suppl 2007; 97: 43-48.
9. Deer T, Krames ES, Hassenbusch SJ, et al,. Polyanalgesic consensus conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation 2007; 10: 300-326.
10. Rietman JS, Geertzen JH,. Efficacy of intrathecal baclofen delivery in the management of severe spasticity in upper motor neuron syndrome. Acta Neurochir Suppl 2007; 97: 205-211.
11. Ballantyne JC, Mao J,. Opioid therapy for chronic pain. N Engl J Med 2003; 349: 1943-1953. (Pubitemid 37409712)
12. Verrotti A, Greco R, Spalice A, Chiarelli F, Iannetti P,. Pharmacotherapy of spasticity in children with cerebral palsy. Pediatr Neurol 2006; 34: 1-6. (Pubitemid 41821001)
13. Ordia JI, Fischer E, Adamski E, Chagnon KG, Spatz EL,. Continuous intrathecal baclofen infusion by a programmable pump in 131 consecutive patients with severe spasticity of spinal origin. Neuromodulation 2002; 5: 16-24. (Pubitemid 34127088)
14. Ordia JI, Fischer E, Adamski E, Spatz EL,. Continuous intrathecal baclofen infusion delivered by a programmable pump for the treatment of severe spasticity following traumatic brain injury. Neuromodulation 2002; 5: 103-107. (Pubitemid 34522387)
15. Hassenbusch SJ, Paice JA, Patt RB, Bedder MD, Bell GK,. Clinical realities and economic considerations: economics of intrathecal therapy. J Pain Symptom Manage 1997; 14: S36-S48. (Pubitemid 27377606)
16. Kumar K, Hunter G, Demeria DD,. Treatment of chronic pain by using intrathecal drug therapy compared with conventional pain therapies: a cost-effectiveness analysis. J Neurosurg 2002; 97: 803-810. (Pubitemid 35222400)
17. Williams JE, Louw G, Towlerton G,. Intrathecal pumps for giving opioids in chronic pain: a systematic review. Health Technol Assess 2000; 4: iii-iiv. 1-65.
18. Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughlin JF,. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg 2003; 98: 291-295. (Pubitemid 36151022)
19. Medtronic, Inc. SynchroMed® II Drug Infusion System Brief Summary. Accessed November 27, 2007.
20. Vender JR, Hester S, Waller JL, Rekito A, Lee MR,. Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients. J Neurosurg Pediatr 2006; 104: 9-15.
21. Albright AL, Ferson SS,. Intrathecal baclofen therapy in children. Neurosurg Focus 2006; 21: e3.
22. Belverud S, Mogilner A, Schulder M,. Intrathecal pumps. Neurotherapeutics 2008; 5: 114-122. (Pubitemid 350299303)
23. Duhon BS, MacDonald JD,. Infusion of intrathecal baclofen for acute withdrawal. Technical note. J Neurosurg 2007; 107: 878-880. (Pubitemid 47547758)
24. Mohammed I, Hussain A,. Intrathecal baclofen withdrawal syndrome-a life-threatening complication of baclofen pump: a case report. BMC Clin Pharmacol 2004; 4: 6.
25. International Standards Organization (ISO) 14708-1:2000. Implants for surgery-active implantable medical devices-Part 1: general requirements for safety, marking and for information to be provided by the manufacturer.
26. Buchler P, Simon A, Burger J, et al,. Safety of active implantable devices during MRI examinations: a finite element analysis of an implantable pump. IEEE Trans Biomed Eng 2007; 54: 726-733. (Pubitemid 46469929)
27. Medtronic, Inc. SynchroMed® MRI Guidelines. Accessed November 24, 2010.
28. Shellock FG, Crivelli R, Venugopalan R,. Programmable infusion pump and catheter: evaluation using 3-Tesla magnetic resonance imaging. Neuromodulation 2008; 11: 163-170. (Pubitemid 352000327)
29. National Research Council. The guide for care and use of laboratory animals. Washington, DC: National Academy Press, 1996.
30. International Electrotechnical Commission (IEC) 60601-2-24: 1998-02. Medical electrical equipment. Particular requirements for the safety of infusion pumps and controllers.
31. International Standards Organization (ISO) 14708-4:2008. Implants for surgery, active implantable medical devices -Part 4: implantable infusion pumps.